334 related articles for article (PubMed ID: 16459163)
21. The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice.
Cui F; Wang Y; Wang J; Wei K; Hu J; Liu F; Wang H; Zhao X; Zhang X; Yang X
Proteomics; 2006 Jan; 6(2):498-504. PubMed ID: 16317774
[TBL] [Abstract][Full Text] [Related]
22. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
Lee Y; Park US; Choi I; Yoon SK; Park YM; Lee YI
Clin Cancer Res; 1998 Jul; 4(7):1711-7. PubMed ID: 9676846
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus X protein induced expression of the Nur77 gene.
Lee MO; Kang HJ; Cho H; Shin EC; Park JH; Kim SJ
Biochem Biophys Res Commun; 2001 Nov; 288(5):1162-8. PubMed ID: 11700033
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.
Zhang X; Dong N; Yin L; Cai N; Ma H; You J; Zhang H; Wang H; He R; Ye L
J Med Virol; 2005 Nov; 77(3):374-81. PubMed ID: 16173017
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3.
Yu FL; Liu HJ; Lee JW; Liao MH; Shih WL
J Hepatol; 2005 Apr; 42(4):520-7. PubMed ID: 15763339
[TBL] [Abstract][Full Text] [Related]
26. Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53.
Dewantoro O; Gani RA; Akbar N
Acta Med Indones; 2006; 38(3):154-9. PubMed ID: 16953033
[TBL] [Abstract][Full Text] [Related]
27. Viral co-factors in liver cancer: lessons from hepatitis B virus.
Butel JS; Lee TH; Slagle BL
Princess Takamatsu Symp; 1995; 25():185-98. PubMed ID: 8875624
[TBL] [Abstract][Full Text] [Related]
28. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
29. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells.
Chan DW; Ng IO
J Pathol; 2006 Feb; 208(3):372-80. PubMed ID: 16353167
[TBL] [Abstract][Full Text] [Related]
30. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells.
Park EH; Koh SS; Srisuttee R; Cho IR; Min HJ; Jhun BH; Lee YS; Jang KL; Kim CH; Johnston RN; Chung YH
Cancer Gene Ther; 2009 May; 16(5):453-61. PubMed ID: 19096445
[TBL] [Abstract][Full Text] [Related]
31. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.
Guo X; Jin Y; Qian G; Tu H
J Hepatol; 2008 Nov; 49(5):718-25. PubMed ID: 18801591
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.
Kim KH; Shin HJ; Kim K; Choi HM; Rhee SH; Moon HB; Kim HH; Yang US; Yu DY; Cheong J
Gastroenterology; 2007 May; 132(5):1955-67. PubMed ID: 17484888
[TBL] [Abstract][Full Text] [Related]
33. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways.
Arbuthnot P; Capovilla A; Kew M
J Gastroenterol Hepatol; 2000 Apr; 15(4):357-68. PubMed ID: 10824878
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma and hepatitis B virus.
Chan HL; Sung JJ
Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
[TBL] [Abstract][Full Text] [Related]
35. COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis.
Cheng AS; Yu J; Lai PB; Chan HL; Sung JJ
Biochem Biophys Res Commun; 2008 Sep; 374(2):175-80. PubMed ID: 18601905
[TBL] [Abstract][Full Text] [Related]
36. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.
Ma NF; Lau SH; Hu L; Xie D; Wu J; Yang J; Wang Y; Wu MC; Fung J; Bai X; Tzang CH; Fu L; Yang M; Su YA; Guan XY
Clin Cancer Res; 2008 Aug; 14(16):5061-8. PubMed ID: 18698024
[TBL] [Abstract][Full Text] [Related]
37. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
38. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus induced hepatocellular carcinoma.
Chemin I; Zoulim F
Cancer Lett; 2009 Dec; 286(1):52-9. PubMed ID: 19147276
[TBL] [Abstract][Full Text] [Related]
40. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis.
Diao J; Garces R; Richardson CD
Cytokine Growth Factor Rev; 2001; 12(2-3):189-205. PubMed ID: 11325602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
